...
首页> 外文期刊>BMC Pulmonary Medicine >Clinical updates of approaches for biopsy of pulmonary lesions based on systematic review
【24h】

Clinical updates of approaches for biopsy of pulmonary lesions based on systematic review

机译:基于系统评价的肺部病变活检方法的临床更新

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Convenient approaches for accurate biopsy are extremely important to the diagnosis of lung cancer. We aimed to systematically review the clinical updates and development trends of approaches for biopsy, i.e., CT-guided PTNB (Percutaneous Transthoracic Needle Biopsy), ENB (Electromagnetic Navigation Bronchoscopy), EBUS-TBNA (Endobroncheal Ultrasonography-Transbronchial Needle Aspiration), mediastinoscopy and CTC (Circulating Tumor Cell). Medline and manual searches were performed. We identified the relevant studies, assessed study eligibility, evaluated methodological quality, and summarized diagnostic yields and complications regarding CT-guided PTNB (22 citations), ENB(31 citations), EBUS-TBNA(66 citations), Mediastinoscopy(15 citations) and CTC (19 citations), respectively. The overall sensitivity and specificity of CT-guided PTNB were reported to be 92.52%?±?3.14% and 97.98%?±?3.28%, respectively. The top two complications of CT-guided PTNB was pneumothorax (946/4170:22.69%) and hemorrhage (138/1949:7.08%). The detection rate of lung cancer by ENB increased gradually to 79.79%?±?15.34% with pneumothorax as the top one complication (86/1648:5.2%). Detection rate of EBUS-TBNA was 86.06%?±?9.70% with the top three complications, i.e., hemorrhage (53/8662:0.61%), pneumothorax (46/12432:0.37%) and infection (34/11250:0.30%). The detection rate of mediastinoscopy gradually increased to 92.77%?±?3.99% with .hoarseness as the refractory complication (4/2137:0.19%). Sensitivity and specificity of CTCs detection by using PCR (Polymerase Chain Reaction) were reported to be 78.81%?±?14.72% and 90.88%?±?0.53%, respectively. The biopsy approaches should be chosen considering a variety of location and situation of lesions. CT-guided PTNB is effective to reach lung parenchyma, however, diagnostic accuracy and incidence of complications may be impacted by lesion size or needle path length. ENB has an advantage for biopsy of smaller and deeper lesions in lung parenchyma. ENB plus EBUS imaging can further improve the detection rate of lesion in lung parenchyma. EBUS-TBNA is relatively safer and mediastinoscopy provides more tissue acquisition and better diagnostic yield of 4R and 7th lymph node. CTC detection can be considered for adjuvant diagnosis.
机译:准确的活检简便方法对肺癌的诊断极为重要。我们旨在系统地回顾活检方法的临床更新和发展趋势,即CT引导下的PTNB(经皮经皮穿刺活检),ENB(电磁导航支气管镜检查),EBUS-TBNA(支气管内超声检查-经支气管针吸术),纵隔镜检查和CTC(循环肿瘤细胞)。进行了Medline和手动搜索。我们确定了相关研究,评估研究资格,评估方法学质量,并总结了CT引导下的PTNB(22次被引),ENB(31次被引),EBUS-TBNA(66次被引),纵隔镜检查(15次被引)和CTC(19次引用)。据报道,CT引导的PTNB的总体敏感性和特异性分别为92.52%±3.14%和97.98%±3.28%。 CT引导的PTNB的前两个并发症是气胸(946/4170:22.69%)和出血(138/1949:7.08%)。以气胸为首发并发症,ENB对肺癌的检出率逐渐提高至79.79%±15.34%(86/1648:5.2%)。 EBUS-TBNA的检出率为86.06%?±?9.70%,其中出血(53/8662:0.61%),气胸(46/12432:0.37%)和感染(34/11250:0.30%)排在前三位)。以嘶哑为难治性并发症的纵隔镜检出率逐渐提高至92.77%±3.99%。据报道,使用PCR(聚合酶链反应)检测CTC的敏感性和特异性分别为78.81%±14.72%和90.88%±0.53%。应考虑各种病变部位和情况选择活检方法。 CT引导的PTNB可有效达到肺实质,但是,病变的大小或针路长度可能会影响诊断的准确性和并发症的发生率。 ENB对肺实质内较小和较深病变的活检具有优势。 ENB加上EBUS成像可以进一步提高肺实质内病变的检出率。 EBUS-TBNA相对更安全,纵隔镜检查可提供更多的组织采集,并能更好地诊断4R和第7淋巴结。可以将CTC检测用于辅助诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号